Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px
Organisation › Details

Celgene Corporation (Nasdaq: CELG)

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. *

 

Period Start 1986-01-01 splitoff
  Group Celgene (Group)
  Predecessor Celanese (Group)
Products Industry pharmaceutical
  Industry 2 cancer drug
     
  Street 86 Morris Avenue
  City 07901 Summit, NJ
  Tel +1-908-673-9000
    Address record changed: 2018-02-03
     
Basic data Employees n. a.
  Currency USD
  Annual sales 898,873,000 (revenue, total, consolidated (2006) 2006-12-31)
  Profit 68,981,000 (2006-12-31)
  Cash 1,982,210,000 (2006-12-31)
     
    * Document for �About Section�: Celgene Corporation. (1/7/18). "Press Release: Celgene to Acquire Impact Biomedicines, Adding Fedratinib to Its Pipeline of Novel Therapies for Hematologic Malignancies". Summit, NJ & San Diego, CA.
     
   
Record changed: 2018-10-31

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px

More documents for Celgene (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px




» top